发表研究结果有使用 ab28432?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab28432 被引用在 8 文献中.

  • Xia Q  et al. Characterization of the transcriptional machinery bound across the widely presumed type 2 diabetes causal variant, rs7903146, within TCF7L2. Eur J Hum Genet N/A:N/A (2014). Human . PubMed: 24667787
  • Kiianitsa K & Maizels N Ultrasensitive isolation, identification and quantification of DNA-protein adducts by ELISA-based RADAR assay. Nucleic Acids Res 42:e108 (2014). PubMed: 24914050
  • Kiianitsa K & Maizels N A rapid and sensitive assay for DNA-protein covalent complexes in living cells. Nucleic Acids Res 41:e104 (2013). WB ; Human . PubMed: 23519618
  • Montariello D  et al. p63 involvement in poly(ADP-ribose) polymerase 1 signaling of topoisomerase I-dependent DNA damage in carcinoma cells. Biochem Pharmacol 85:999-1006 (2013). Human . PubMed: 23376119
  • Pfister TD  et al. Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues. PLoS One 7:e50494 (2012). Human . PubMed: 23284638
  • D'Onofrio G  et al. Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells. Biochem Pharmacol 81:194-202 (2011). WB ; Human . PubMed: 20875401
  • Pfister TD  et al. Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther 8:1878-84 (2009). ELISA ; Human . PubMed: 19584232
  • Cohen AA  et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 322:1511-6 (2008). WB ; Human . PubMed: 19023046

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"